Home · Health · Nov 17 archive
White House Withdraws Overton's FDA Nomination Amid Senate Opposition
· Confirmed
In Short: The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA) amid growing opposition from Senate Republicans.

Heidi Overton (Wikidata P18).
Trump's pick Heidi Overton dropped as nominee for FDA commissioner. ABC News
The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA) amid growing opposition from Senate Republicans.
Overton faced a contentious hearing in September when the HELP Committee questioned her ability to act independently from President Donald Trump.
Senate Republicans, including Sen. Bill Cassidy, expressed reservations about Overton's nomination, citing her support for Trump's executive order on childhood vaccines.
Overton stood beside Trump when he announced an executive order to break up combination vaccines, including the measles, mumps, and rubella (MMR) vaccine, a move that has drawn criticism.
Sen. Roger Marshall has been suggested as a possible replacement for Overton, according to Semafor.
Overton's nomination was set to face a key vote on Wednesday in the Senate health committee, where Republicans hold a one-vote majority.
The White House said Overton lacked the necessary support to win Senate confirmation, with Cassidy stating that a series of short-term administrators might be preferable to a permanent commissioner.
Overton's White House record, including her support for Trump's vaccine policies, appeared to work against her during the confirmation process.
The FDA has lost its measles elimination status amid a growing number of cases and deaths, raising further questions about Overton's nomination.
What this adds
The White House has withdrawn Overton's nomination amid concerns over insufficient congressional support, reflecting a broader pattern of opposition from Senate Republicans.
Background
The White House has withdrawn Heidi Overton's nomination to lead the Food and Drug Administration amid concerns over insufficient congressional support.
The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA) amid opposition from Senate Republicans.
What's confirmed
- Sen. Roger Marshall (R-KS) has been suggested as a possible replacement for Overton, Semafor reported on Tuesday.
- On Tuesday evening, the White House pulled Overton’s nomination to become the next FDA commissioner as the Trump advisor and physician faced opposition from Senate Republicans, the administration confirmed to The Hill.
- Overton was set to face a key vote on Wednesday in the Senate health committee, where the Republicans hold a one-vote majority.
- The Trump administration withdrew its nomination of White House health aide Heidi Overton to lead the Food and Drug Administration Tuesday amid opposition from Senate Republicans, a White House official confirmed to MS NOW.
- The White House on Nov. 17 withdrew the nomination of Heidi Overton, M.D., Ph.D., to lead the Food and Drug Administration (FDA), one day before the Senate Health, Education, Labor and Pensions (HELP) Committee was scheduled to vote on whether to send her to the full Senate.
- Trump administration official says it appeared that Overton, a physician and abortion opponent, lacked the votes necessary for Senate confirmation Trump administration official says it appeared that Overton, a physician and abortion opponent, lacked the votes necessary for Senate confirmation The White House has dropped its nomination of Heidi Overton to lead the Food and Drug Administration, a White House official told the Guardian.
- The top Republican on the Senate health committee said he was undecided on whether to support Overton ahead of a key vote on her nomination set for Wednesday.
- Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for President Donald Trump or conservative groups aligned with his agenda.
- WASHINGTON (AP) — The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation.
- The White House is dropping President Donald Trump’s nomination of Heidi Overton to lead the Food and Drug Administration (FDA) amid a lack of congressional support, as Sen. Roger Marshall (R-KS) is reportedly being considered as a potential replacement.
- Overton stood beside Trump when he announced an executive order to reduce and separate the childhood vaccine schedule.
What's still developing
- A vote in Overton’s favor was looking increasingly unlikely, however, as rumblings from certain Senators and media outlets over the past few days made clear.
- Some Trump administration officials had grown “skeptical” that the Senate would confirm Overton, “prompting them to discuss whether to attempt to shore up her nomination or abandon it altogether,” The Washington Post reported on Monday, citing four individuals familiar with the matter.
- The senator elaborated on his concerns regarding Overton on CBS ’s Face the Nation on Sunday.
- A senior administration official told Axios that Overton did not have enough support to be confirmed as the next FDA commissioner after she faced skepticism from some Republicans over her role in the administration's efforts to change childhood vaccine recommendations.
- Before Overton’s confirmation hearing in September, Cassidy wrote on X that he had “strong concerns” about her nomination, saying her lack of managerial experience left her poorly prepared to lead the agency.
- Republicans have only a narrow window to confirm dozens of Trump administration nominees before Democrats take over Congress next year. (Francis Chung/POLITICO/AP) The White House is dropping Heidi Overton’s nomination for commissioner of the Food and Drug Administration amid pressure campaigns by anti-abortion and anti-vaping advocates, according to a White House spokesperson.
- Numerous news outlets, starting with Axios, are reporting that the White House has decided to pull the nomination of Heidi Overton to lead the FDA.
- Prior to joining the White House, Overton worked as chief policy officer at the conservative think tank America First Policy Institute.
- Trump nominated Overton, a preventive medicine physician and deputy director of the White House Domestic Policy Council, in August, three months after the resignation of former FDA Commissioner Marty Makary, turning to an “America First” ally to steady a Food and Drug Administration that has lost more than 4,500 staff over the past year.
- Bill Cassidy, a lame duck Republican senator, has expressed reservations about Overton because of his role in drafting an executive order issued in August 2026 that calls for recategorizing childhood vaccines so some are recommended only for high-risk groups and others, including vaccines against COVID-19 and hepatitis A and B, are left to shared decision-making between parents and clinicians.
Sources
- BioSpacelink
- Breitbartlink
- CBS Newslink
- Fox Newslink
- Justthenewslink
- KOMOlink
- MS NOWlink
- Medical Economicslink
- NBC Newslink
- NOTUSlink
- New York Postlink
- Ntdlink
- STATlink
- The Guardianlink
- The Ritz Heraldlink
- reflector.comlink
- ABC News — video link
- WUSA9 — video link
- The 60 Second News — video link
- The Future Wire — video link
